Axogen, Inc. (AXGN)
NASDAQ: AXGN · Real-Time Price · USD
48.73
+0.68 (1.42%)
At close: Aug 14, 2026, 4:00 PM EDT
48.50
-0.23 (-0.47%)
Pre-market: Aug 17, 2026, 8:20 AM EDT

Axogen Revenue

Axogen had revenue of $69.73M in the quarter ending June 30, 2026, with 23.06% growth. This brings the company's revenue in the last twelve months to $251.17M, up 23.57% year-over-year. In the year 2025, Axogen had annual revenue of $225.21M with 20.21% growth.

Revenue (ttm)
$251.17M
Revenue Growth
+23.57%
P/S Ratio
10.43
Revenue / Employee
$403,817
Employees
622
Market Cap
2.62B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025225.21M37.87M20.21%
Dec 31, 2024187.34M28.33M17.81%
Dec 31, 2023159.01M20.43M14.74%
Dec 31, 2022138.58M11.23M8.81%
Dec 31, 2021127.36M15.06M13.41%
Dec 31, 2020112.30M5.59M5.24%
Dec 31, 2019106.71M22.78M27.13%
Dec 31, 201883.94M23.51M38.91%
Dec 31, 201760.43M19.32M46.99%
Dec 31, 201641.11M13.78M50.41%
Dec 31, 201527.33M10.51M62.52%
Dec 31, 201416.82M5.87M53.62%
Dec 31, 201310.95M3.26M42.33%
Dec 31, 20127.69M2.84M58.61%
Dec 31, 20114.85M1.85M61.41%
Dec 31, 20103.00M--
Dec 31, 2009---
Dec 31, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Integer Holdings1.84B
Haemonetics1.35B
Inspire Medical Systems898.74M
Neogen870.40M
iRhythm Holdings825.34M
NovoCure699.19M
TransMedics Group668.47M
UFP Technologies631.64M
Revenue Rankings